Semaglutide has emerged as a promising treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to release more insulin and reducing glucagon https://izaakpasq960294.tkzblog.com/35454568/understanding-semaglutide-a-comprehensive-guide